Search

The article reports that the chemical manufacturers in Europe have been trying to end the production of mercury-based chlor-alkali. It states that the companies are racing to meet an end-of-2017 deadline to move to free method of manufacturing chlorine and caustic soda. It mentions that some of the chemical companies have not embraced the deadline on December 11, 2017.

Reports on European bulk antibiotic producers' response to low prices with restructuring that combines layoffs with investment in various technologies and products. Annual value of the global finished antibiotics market; Corporate downsizing of Italy's Antibiotics at its plants in Turin and Milan; Plan of Netherlands-based DSM to restor profitability in its anti-infectives business group.

The article presents information on the importance of shale gas which is a natural gas extracted from the shale deposits. The chemical industry of the U.S. is surviving as compared to other countries like China and few countries of Europe due to the cheap natural gas even though the economy of the country is stagnant. Information on an annual meeting and a press conference regarding the impact of shale gas on the chemical industry of the U.S. is also presented.

Focuses on the slowdown in the second-quarter earnings in the core pharmaceutical businesses of big U.S. drug companies, due to patent expirations and product recalls. Better performance of European drug-makers compared to their U.S. counterparts; Comparison of the earnings of U.S. and European drug companies; Rise in the earnings of Wyeth Laboratories Inc. as well as Johnson & Johnson, while that of Pfizer and Merck & Co. Inc., plunged.

Reports on the financial performance of the pharmaceutical industry in the United States and Europe for the first-quarter of 2005. AstraZeneca PLC's growth leader; Johnson and Johnson Inc. and Pfizer Inc.'s strong performers; Increase in Wyeth Laboratories Inc.'s sales and earnings; Profit margin.

The article reports on the progress in the development of shale gas in the U.S. It states that chemical companies in Europe and India plan to modify their petrochemical crackers to run on low-cost ethane imported from the U.S. It further mentions that companies such as India-based Reliance Industries, Austrian firm Borealis and many others are revamping their crackers to utilize ethane imported from U.S.

The article discusses the economic condition of the chemical industry in Europe. It notes that executives of companies announced with optimism their earnings for the third quarter of 2009. An overview of the earnings trend of various companies including Bayer AG, BASF AG, and Merck & Co. Inc. is included. Moreover, stock analysts are impressed with the reported earnings and suggest that the worst in the economy is falling behind them.

The article reports on the acquisitions made by pharmaceutical companies, Sanofi-Aventis SA and Ranbaxy Laboratories Ltd., in Europe. Sanofi, which has just acquired 24.9 percent interest of Czech generic company, Zentiva AS, refers the move as part of its strategy to expand in Central and Eastern Europe. On the other hand, Ranbaxy will pay Advent International Corp. for a 97 percent stake in Terapia.